Glycine — Research Evidence

The available research on glycine supplementation spans multiple biological pathways and health outcomes, but the evidence base is uneven in quality and scope. The strongest signal comes from a randomized clinical trial (GlyNAC study) examining glycine combined with N-acetylcysteine in older adults, which found improvements in glutathione deficiency, oxidative stress, mitochondrial function, inflammation, and physical function — suggesting that glycine's role as a rate-limiting precursor for glutathione synthesis may have real clinical relevance, especially in aging populations. Glycine's structural role in collagen is well-established biochemically, and RCT evidence supports that vitamin C-enriched gelatin (which contains glycine) can augment collagen synthesis when taken before intermittent exercise, though this involved a multi-ingredient product rather than glycine in isolation. A systematic review on glycine's physiological effects in human adults provides some organized clinical evidence, but the overall picture is constrained by small sample sizes, short intervention durations, and heterogeneous study designs.

Across the reviewed literature, glycine emerges as a conditionally essential amino acid — meaning dietary intake may become insufficient under conditions of aging, high physiological stress, or elevated metabolic demand, even though the body can synthesize it. This conditional essentiality is supported indirectly by findings showing that endogenous glycine synthesis appears inadequate to meet total-body demands in older adults. Its roles as a precursor to creatine and glutathione are biochemically well-established and corroborated by mechanistic and clinical data in the reviewed studies. Reviews on bone broth, collagen, and glycine's multifarious benefits provide supporting context, though these are narrative reviews rather than controlled trials and carry inherent limitations in establishing causality.

Important caveats temper enthusiasm. The majority of claims about glycine — 137 out of 176 evaluated — were rated as having insufficient evidence, meaning much of what is discussed in the literature remains speculative or insufficiently tested in humans. Most studies are short-term, conducted in narrow populations (such as older adults or athletes), and many glycine-containing interventions use combination products (e.g., GlyNAC, gelatin plus vitamin C), making it difficult to attribute effects to glycine alone. Long-term safety data in supplemental doses are sparse, dose-response relationships are poorly characterized, and it remains unclear which populations would benefit most. The research on collagen synthesis, gut barrier support, and anti-inflammatory effects is promising but preliminary in humans.

Studies (20)